Start with the lot number and the label layout. FDA has flagged three counterfeit lots of Ozempic 1 mg in the U.S. supply chain: NAR0074, PAR0362 and PAR1229 [1]. The December 2023 seizure ran to thousands of units. PAR1229 is also an authentic lot, so the tell is on the pen itself. Counterfeit labels print “EXP/LOT” to the left of the date and lot number, while authentic ones print it above.
When you verify the dispensing pharmacy, use its state licensing record and contact the pharmacy directly. The lot and label checks below address specific counterfeits identified by FDA. A matching package alone cannot verify where the medication came from.
The three FDA alerts, by date
December 21, 2023: FDA had seized thousands of units of counterfeit Ozempic 1 mg [1]. It named lot NAR0074 with serial number 430834149057. The needles were counterfeit, so their sterility could not be confirmed and the infection risk was higher.
That alert also listed the pen label, the patient and professional information, and the carton as confirmed counterfeit components [1]. FDA knew of five adverse events from that lot, and none was serious.
April 14, 2025: Novo Nordisk told FDA of several hundred counterfeit units on April 3 [1]. FDA seized them on April 9, and the alert named lot PAR0362 with serial numbers starting 51746517.
December 5, 2025: FDA had seized dozens of units labeled lot PAR1229 [1]. That number also appears on authentic pens. The counterfeit prints the “EXP/LOT” text on the left side of the expiration date and lot number.
FDA says pens from lot PAR1229 received through Novo Nordisk’s Patient Assistance Program are authentic [1]. Testing of the seized product was still under way when that alert was posted.
What to check on a pen or package
Each check below is a condition, and a product that fails any one of them should not be injected.
The form must match the label. Ozempic injection is supplied as multi-dose pens and single-dose prefilled syringes [3]. A vial labeled Ozempic is not a listed presentation on that label.
The solution must be clear and colorless. The label says not to use Ozempic if particles or coloration are seen [3].
Check the lot, serial number and label together against the relevant alert. Authentic pens also carry lot PAR1229, so use the label details FDA provides for that alert. Pharmacists can confirm a batch with Novo Nordisk customer care at 1-800-727-6500 [1].
The package must look like earlier fills. FDA lists medicine that looks different from before, or arrives in damaged packaging, as a warning sign [7]. Ask the dispensing pharmacy to check any differences before using it.
What fake semaglutide has contained
The harm on record is not only a weak dose. In Italy, a 31-year-old woman was admitted in a hypoglycemic coma after injecting “Ozempic” bought from a website [4]. Toxicology found insulin in the vial instead of semaglutide.
Two Dutch cases followed the same pattern [5]. Neither patient had diabetes or obesity, and both had obtained semaglutide without a prescription. Both arrived in a coma with severe hypoglycemia. The authors attributed both cases to synthetic insulin exposure.
These reports describe people whose clinicians investigated possible insulin exposure after severe hypoglycemia [4] [5]. Low blood sugar alone cannot identify the contents of an injection.
What the European reports add
A study searched the EU’s pharmacovigilance database from 2018 through 2025 [6]. It identified 234 reports involving suspected counterfeit semaglutide. The study classified 209 of those reports (89.3%) as serious.
Vomiting, nausea and hypoglycemia were reported most often [6]. Against other semaglutide reports, suspected counterfeit cases more often included hypoglycemia or reports that the product did not work. The study could compare reporting patterns. It could not estimate how often these problems occur among people who use the products.
Where the risk sits
FDA separates counterfeits from a second problem [2]. Some compounded semaglutide and tirzepatide carries a label naming a pharmacy that does not exist. Other labels name a licensed pharmacy that did not make the product.
If you are evaluating an online semaglutide offer, start with FDA’s advice to fill a valid prescription at a state-licensed pharmacy [2]. Researchers who ordered semaglutide from sites that skipped prescriptions found problems that were apparent only after purchase and testing. A product listing cannot tell you what will arrive.
Keep the package and contact the dispensing pharmacist if you suspect a counterfeit. FDA advises against using products that match its counterfeit alerts and accepts reports through its safety reporting portal [1].